Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Two Pulsed Field Ablation Systems for Atrial Fibrillation: One-Year Outcomes From a Multicenter Registry.

Journal of cardiovascular electrophysiology·2026
Same author

Multicenter analysis of device-detected atrial fibrillation burden reduction after antiarrhythmic drug initiation.

Heart rhythm O2·2026
Same author

Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.

JACC. Clinical electrophysiology·2026
Same author

Postoperative Atrial Arrhythmias After Lung Transplantation: A Single Center Analysis of Risk Factors, Management, and Outcomes.

Clinical transplantation·2026
Same author

"Response by Kalluri et al. to Letter Regarding Article," "Catheter Ablation: Evolution and Efficiencies".

Journal of cardiovascular electrophysiology·2026
Same author

Recurrent Myocarditis After COVID Vaccination in a Patient With FLNC Mutation Undergoing Treatment for Lymphoma.

JACC. Case reports·2026
Same journal

Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies.

Progress in cardiovascular diseases·2026
Same journal

Multimodality imaging of vulnerable plaque: Are we there yet? A multifaceted perspective.

Progress in cardiovascular diseases·2026
Same journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same journal

COVID-19 and coronary atherosclerosis: Unmasking and accelerating?

Progress in cardiovascular diseases·2026
Same journal

Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block.

Progress in cardiovascular diseases·2026
Same journal

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
See all related articles

Related Experiment Video

Updated: Apr 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K

Left atrial appendage closure.

Albert C Lin1, Bradley P Knight1

  • 1Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.

Progress in Cardiovascular Diseases
|August 5, 2015
PubMed
Summary
This summary is machine-generated.

Atrial fibrillation (AF) increases stroke risk due to left atrial appendage (LAA) thrombus. LAA closure offers an alternative to oral anticoagulation for preventing AF-related stroke and embolism.

Keywords:
Atrial fibrillationLeft atrial appendageLeft atrial appendage closure

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.5K

Related Experiment Videos

Last Updated: Apr 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.5K

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Biomedical Engineering

Background:

  • Atrial fibrillation (AF) is a common arrhythmia associated with a significantly increased risk of stroke and systemic embolism.
  • Thrombus formation in the left atrial appendage (LAA) is the primary mechanism underlying AF-related thromboembolic events.
  • The unique anatomy of the LAA and loss of atrial systole in AF contribute to thrombus development.

Purpose of the Study:

  • To evaluate left atrial appendage (LAA) closure as an alternative strategy for stroke prevention in patients with atrial fibrillation (AF).
  • To compare the efficacy and safety of LAA closure versus traditional oral anticoagulation therapies in reducing thromboembolic events.

Main Methods:

  • Review of existing clinical studies and meta-analyses on LAA closure devices and oral anticoagulants in AF patients.
  • Analysis of data regarding stroke, systemic embolism, and bleeding events in patients undergoing LAA closure versus those on anticoagulation.
  • Assessment of the anatomical and functional characteristics of the LAA predisposing to thrombus formation.

Main Results:

  • LAA closure has demonstrated significant efficacy in preventing stroke and systemic embolism in AF patients.
  • While oral anticoagulation is effective, it carries an inherent risk of bleeding complications.
  • LAA closure presents a viable alternative for patients who are unsuitable for or intolerant to long-term oral anticoagulation.

Conclusions:

  • Left atrial appendage (LAA) closure is a promising therapeutic option for reducing the risk of stroke and systemic embolism in patients with atrial fibrillation (AF).
  • This interventional approach provides an alternative to oral anticoagulation, particularly for individuals at high risk of bleeding.
  • Further research and long-term data are essential to fully elucidate the role of LAA closure in AF management.